Health Claim Rejected as "Diagnostic Admission" Despite Doctor Certifying Medical Necessity

A working professional held a family health insurance policy for which a premium of roughly forty thousand rupees was paid each year. She had also maintained a long-standing relationship with the same financial group through a corporate health cover and a family savings account. Despite this loyalty, when a genuine medical emergency arose, she found herself in a prolonged dispute with the insurer.

The policyholder was admitted to a specialist gastroenterology hospital after developing a combination of persistent high fever, severe abdominal pain, repeated vomiting, loose stools, and significant generalised weakness. Her condition deteriorated rapidly, making it impossible for her to manage the symptoms at home. A qualified gastroenterologist assessed her clinical presentation and decided that inpatient admission was necessary for close monitoring, stabilisation of blood pressure and hydration status, investigation of the underlying cause, and timely treatment. During her stay she received medication including insulin, and investigations confirmed a stomach ulcer. The treating doctor subsequently issued a formal written query response, signed and stamped, stating that the admission was medically justified and necessary.

The insurer, however, rejected the claim citing a standard policy exclusion for admissions undertaken primarily for diagnostic or investigative purposes. In the rejection communication, the insurer referenced the investigation and evaluation exclusion clause in the policy wordings and offered no further clinical reasoning.

The policyholder raised an escalation, attaching all medical records, prescriptions, the hospital discharge summary, and the doctor's written certification of medical necessity. She argued, reasonably, that a patient cannot be penalised for following a qualified doctor's advice to undergo investigations that are part of an inpatient treatment plan. She received no substantive response for several days.

This pattern is common in health insurance disputes. An insurer applies the diagnostic-purpose exclusion broadly, treating any admission that involves tests as one that exists solely for investigation, without distinguishing between an admission driven by diagnostic curiosity and one driven by an acute clinical condition that requires monitoring and active treatment alongside investigation. In this case the clinical picture, acute multi-symptom presentation, haemodynamic monitoring, fluid and electrolyte management, and active pharmacological treatment, pointed clearly to a therapeutic admission in which investigations were incidental rather than the primary purpose.

The policyholder had clear grounds to challenge the rejection. A written representation to the insurer is the first required step. If the insurer rejects it or does not reply within one month, the complaint may be escalated to the Insurance Ombudsman, which charges no filing fee. Separately, a grievance may also be registered through the IRDAI portal. The Ombudsman, where a complaint is not settled by mediation, is required to pass an award within three months of receiving all requirements from the complainant, and any award passed is binding on the insurer.

What went wrong

• The insurer applied the diagnostic-purpose exclusion mechanically without assessing the full clinical picture of an acute multi-symptom presentation.
• The rejection letter cited only a policy clause reference and offered no case-specific clinical reasoning or engagement with the submitted medical records.
• Active inpatient treatment, including medication and insulin administration, was apparently not distinguished from a purely investigative admission.
• The insurer failed to acknowledge or counter the treating specialist's formal written certification that the admission was medically necessary.
• The policyholder received no substantive response for several days after escalating to senior management, compounding the distress.
• A long-standing policyholder relationship, including corporate cover and a family banking relationship, appears to have carried no weight in the review process.

What evidence mattered

• Treating doctor's formal written certification of medical necessity, signed and stamped, explicitly stating that inpatient admission was required for stabilisation and treatment and not merely for investigation.
• Discharge summary showing active therapeutic interventions, such as IV fluids, medication administration, and insulin, alongside the diagnostic workup.
• Nursing observation or monitoring records showing frequency of vital sign checks, which support an argument of inpatient monitoring necessity.
• Investigation reports confirming a clinical diagnosis arrived at during the admission, demonstrating that tests led to treatment rather than existing as the end goal.
• Complete prescription and medication chart from the hospital stay.
• Written rejection letter from the insurer specifying the exact exclusion clause applied, to be used as the basis for a point-by-point rebuttal in the escalation.

The escalation route that applies

1. 1.Step 1: Send a formal written representation to the insurer's grievance cell, attaching the doctor's medical necessity certificate, discharge summary, medication chart, investigation reports, and a point-by-point rebuttal of the diagnostic-exclusion reasoning.
2. 2.Step 2: If the insurer rejects the representation or does not reply within one month of receiving it, the complaint becomes eligible for the Insurance Ombudsman. No filing fee is payable to the Ombudsman.
3. 3.Step 3: File a complaint with the Insurance Ombudsman in the jurisdiction covering the insurer's branch. The complaint must be in writing, signed by the complainant, and must state the facts, the nature of the loss, and the relief sought. It must be filed within one year of the insurer's rejection or the expiry of the one-month reply period.
4. 4.Step 4: Simultaneously or independently, register a grievance on the IRDAI portal (Bima Bharosa). Note that this is a separate regulatory route and does not by itself satisfy the written-representation precondition for the Ombudsman.
5. 5.Step 5: If the matter is not resolved through the above routes, the policyholder may approach a consumer disputes forum or other competent legal authority, bearing in mind that once a matter is pending before a court or consumer forum, the Ombudsman cannot entertain it in parallel.

Solvh's take

This case illustrates one of the most frequently misapplied exclusions in Indian health insurance: the diagnostic or investigative admission exclusion. Insurers sometimes use it as a catch-all to deny claims where the discharge summary shows a significant proportion of the stay devoted to tests, without examining whether those tests were ordered as part of active inpatient treatment of an acute condition.

The clinical facts here cut strongly against a pure diagnostic interpretation. The policyholder presented with multiple simultaneous acute symptoms, including fever, severe pain, vomiting, weakness, and fluid imbalance. These are not the presenting complaints of a person seeking elective investigation. They are the presenting complaints of someone who required urgent clinical management. The treating specialist's written query response, certifying that the admission was medically necessary for stabilisation and treatment, is precisely the kind of contemporaneous clinical documentation that regulatory adjudicators and ombudsmen give significant weight to.

The insurer's failure to engage with that certification and to provide a detailed clinical counter-argument in its rejection letter suggests the claim may have been processed through an automated or formulaic review rather than a case-specific clinical assessment. This is a systemic risk in high-volume health claims operations: exclusion codes are applied pattern-matched against certain keywords in discharge summaries rather than against the full clinical narrative.

From a policyholder advocacy standpoint, the key insight is that the diagnostic exclusion is not a blanket bar on any admission in which tests are performed. The exclusion is directed at admissions whose sole or primary purpose is investigation in the absence of an acute therapeutic need. Where the clinical record shows active treatment running alongside investigation, the exclusion ordinarily should not apply. A well-structured written representation, supported by the treating doctor's certificate, the discharge summary, the medication chart, and nursing notes showing monitoring frequency, gives the policyholder a strong factual basis to seek reconsideration or escalation.